RESUMEN
The effects of thyme (Thymus vulgaris L.) leaves and its phenolic compounds, thymol and carvacrol, on the activities of xenobiotic-metabolizing enzymes, i.e., phase I enzymes such as 7-ethoxycoumarin O-deethylase (ECOD) and phase II enzymes such as glutathione S-transferase (GST) and quinone reductase (QR), were investigated. Mice were fed with a diet containing thyme (0.5% or 2.0%) or treated orally with thymol (50-200 mg/kg) or carvacrol (50-200 mg/kg) once a day for 7 successive days, and then the enzyme activities in the livers were analyzed. Dietary administration of 2% thyme caused slightly but significantly higher ECOD, GST, and QR activities by 1.1-1.4-fold. Thymol (200 mg/kg) treatment resulted in significantly higher ECOD, GST, and QR activities by 1.3-1.9-fold, and carvacrol (200 mg/kg) treatment caused significantly higher ECOD, GST, and QR activities by 1.3-1.7-fold. Thymol-treated animals had significantly higher protein levels of GST alpha and GST micro, and carvacrol-treated animals had significantly higher levels of GST micro. These results imply that thyme contains bifunctional inducers (i.e., substances capable of inducing both phase I and phase II enzymes) and that thymol and carvacrol may account for the effects of thyme.
Asunto(s)
Hígado/enzimología , Monoterpenos/farmacología , Extractos Vegetales/farmacología , Timol/farmacología , Thymus (Planta)/química , Xenobióticos/metabolismo , 7-Alcoxicumarina O-Dealquilasa/metabolismo , Animales , Western Blotting , Cimenos , Relación Dosis-Respuesta a Droga , Electroforesis en Gel de Poliacrilamida , Glutatión Transferasa/metabolismo , Hígado/efectos de los fármacos , Masculino , Ratones , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Tamaño de los Órganos/efectos de los fármacos , Hojas de la Planta , Distribución AleatoriaRESUMEN
Modifying effect of fermented brown rice by Aspergillus Oryzae (FBRA) during the initiation or post-initiation phase of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis was investigated in rats. Five-week-old male F344 rats were divided into 7 groups, and groups 1-5 were given subcutaneous injections of NMBA (0.5 mg/kg body weight/injection 15 times) for 5 weeks starting at 7 weeks of age. Groups 2 and 4 were fed the diet containing 5 and 10% FBRA during the initiation phase, respectively, whereas groups 3 and 5 were fed these diets during the post-initiation phase. Group 6 was given the diet containing 10% FBRA throughout the experiment, and group 7 was kept on the basal diet alone and served as an untreated control. Incidence and multiplicity of esophageal neoplasms of group 1 (NMBA alone) were 89% and 1.63+/-1.01/rat, respectively. Those of groups 3 (65%, 1.04+/-1.04) and 5 (58%, 0.77+/-0.86) were significantly less than those of group 1. Furthermore, the incidence and multiplicity of esophageal preneoplastic lesions (dysplasia) of group 5 were less than those of group 1. Post-initiation feeding of 10% FBRA significantly decreased BrdU incorporation in the non-lesional esophageal tissues when compared to that of the control. In addition, the analysis of expression levels of phase I enzymes of livers at the termination of experiment showed no clear differences among the groups. These observations indicate for the first time that FBRA inhibits NMBA-induced esophageal tumor development in rats possibly through inhibition of cell proliferation in the post-initiation phase, and suggest that FBRA is a promising dietary agent for prevention of human esophageal cancer.
Asunto(s)
Dimetilnitrosamina/análogos & derivados , Neoplasias Esofágicas/prevención & control , Oryza/química , Administración Oral , Alimentación Animal , Animales , Carcinógenos/administración & dosificación , Carcinógenos/farmacología , Proliferación Celular/efectos de los fármacos , Dieta , Dimetilnitrosamina/administración & dosificación , Dimetilnitrosamina/farmacología , Neoplasias Esofágicas/inducido químicamente , Neoplasias Esofágicas/veterinaria , Fermentación , Masculino , Neoplasias Experimentales , Extractos Vegetales/farmacología , Ratas , Ratas Endogámicas F344RESUMEN
The modifying effects of dietary feeding of extract of leaves of ginkgo (Ginkgo biloba) (EGb) and bilobalide isolated from EGb on the development of azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF) were investigated in male F344 rats. We also assessed the effects of EGb and bilobalide on proliferating cell nuclear antigen (PCNA) index in 'normal-appearing' crypts and activities of detoxifying enzymes of cytochrome P450 (CYP), glutathione S-transferase (GST) and quinine reductase (QR) activity in the liver. To induce ACF, rats were given two weekly subcutaneous injections of AOM (20 mg/kg body wt). They also received the experimental diets containing EGb (50 or 500 ppm) and bilobalide (15 or 150 ppm) for 4 weeks, starting 1 week before the first dosing of AOM. AOM exposure produced a substantial number of ACF (106 +/- 10) at the end of the study (week 4). Dietary administration of EGb and bilobalide caused significant reduction in the frequency of ACF: 50 ppm EGb, 73 +/- 17 (31% reduction, P < 0.001); 500 ppm EGb, 56 +/- 13 (47% reduction, P < 0.001); 15 ppm bilobalide, 79 +/- 17 (25% reduction, P < 0.001); and 150 ppm bilobalide, 71 +/- 30 (33% reduction, P < 0.01). Immunohistochemically, EGb or bilobalide administration significantly lowered PCNA index in normal-appearing crypts. Feeding with EGb or bilobalide increased activities of CYP as well as GST and QR in the liver. These findings might suggest possible chemopreventive ability of EGb or bilobalide, through alterations in cryptal cell proliferation activity and drug metabolizing enzymes' activities, in colon tumorigenesis.
Asunto(s)
Neoplasias del Colon/prevención & control , Ciclopentanos/farmacología , Diterpenos/farmacología , Furanos/farmacología , Ginkgo biloba/química , Fitoterapia , Extractos Vegetales/farmacología , Lesiones Precancerosas/prevención & control , Administración Oral , Animales , Azoximetano/administración & dosificación , Azoximetano/toxicidad , Carcinógenos/administración & dosificación , Carcinógenos/toxicidad , Quimioprevención , Neoplasias del Colon/fisiopatología , Neoplasias del Colon/veterinaria , Sistema Enzimático del Citocromo P-450/farmacología , Dieta , Ginkgólidos , Glutatión Transferasa/farmacología , Inmunohistoquímica , Masculino , Hojas de la Planta/química , Lesiones Precancerosas/fisiopatología , Lesiones Precancerosas/veterinaria , Antígeno Nuclear de Célula en Proliferación/análisis , Ratas , Ratas Endogámicas F344RESUMEN
The effects of a standardized extract of Ginkgo biloba L. leaves (EGb) and its terpene constituents, bilobalide and ginkgolides, on the activities of detoxification enzymes, i.e., glutathione S-transferases (GSTs) and DT-diaphorase, and glutathione contents, were investigated in the mouse liver. Oral treatment with EGb (100-1,000 mg/kg) and bilobalide (10-30 mg/kg) once a day for 4 days caused a dose-dependent elevation in GST activity. Ginkgolide A (30 mg/kg, for 4 days) also significantly elevated GST activity, whereas ginkgolide B and ginkgolide C at the same dose had no effects. EGb significantly increased the protein level of GST pi, and bilobalide significantly increased those of GST alpha and GST mu Moreover, EGb-treatment and bilobalide-treatment caused significant elevations in DT-diaphorase activity and in hepatic glutathione contents.